Obesity, particularly abdominal obesity, is associated with increased risks of hypertension, diabetes, hyperlipidemia, sleep apnea, coronary heart disease, and stroke. 3,4 In the United States, health care expenditures related to obesity and asso ciated medical conditions amount to $100 billion annually, 5 and in 2000, obesity was estimated to contribute to approximately 400,000 deaths. 6 It has been suggested that in the 21st century, increasing rates of obesity may lead to a decline in overall life expectancy in the United States. 7
ing portions of the small intestine where nutrient absorption occurs.
Restrictive procedures include gastric stapling (gastroplasty), adjustable gastric banding (wrap ping a synthetic, inflatable band around the stom ach to create a small pouch with a narrow out let), or a combination of these two approaches. Adjustable gastric banding is a relatively new op eration that includes the insertion of a subcuta neous reservoir so that gastric restriction can be adjusted by means of saline injections. The proce dure can be performed laparoscopically, and the band can be removed in an outpatient setting without anesthesia (Fig. 1A) . 12 Another recently developed procedure is the vertical restrictive (sleeve) gastrectomy (Fig. 1B) , in which resection of much of the gastric body leaves a narrow tube of stomach as an alimentary conduit.
Proximal RouxenY gastric bypass ( Fig. 1C ) is often referred to as a combination restrictionmalabsorption procedure. It involves stapling of the stomach to create a small (≤30.0 ml) upper gastric pouch. The small intestine is then divided at the midjejunum, and the distal portion (called the alimentary, or Roux, limb) is anastomosed to the gastric pouch. The distal portion of the stomach and proximal small intestine (the bilio pancreatic limb) are anastomosed end to side farther down the jejunum. Food comes into con tact with pancreatic and biliary secretions only below this anastomosis, in the segment of small intestine called the common channel. The shorter the common channel (and the longer the Roux limb), the less nutrient absorption will occur. 13 Malabsorptive procedures that introduce less gastric restriction than the RouxenY procedure include biliopancreatic diversion, commonly done by means of a procedure called duodenal switch, which includes sleeve (vertical) gastrectomy (Fig.  1D) . Some surgeons perform a sleeve gastrectomy (Fig. 1B) as the initial part of a staged operation, performing a RouxenY procedure after initial weight loss has made surgery less difficult and reduced the operative risk.
Cl inic a l E v idence
No large, randomized trials have compared cur rent bariatric surgical techniques with medical management of severe obesity. A 2005 Cochrane Review identified only two small, randomized, controlled trials and three cohort studies, all of which were considered to have a high risk of bias in their design. 14 Nonetheless, their summary as sessments, as well as those of two metaanalyses, suggest a typical weight loss of 20 to 50 kg (44 to 110 lb) with various bariatric procedures as com pared with a modest weight gain in medically treated patients. [14] [15] [16] The only large, wellcontrolled prospective study of bariatric surgery is the Swedish Obese Subjects (SOS) trial. 17 A total of 2010 surgically treated obese patients (BMI, 34 or more for men and 38 or more for women) were compared with 2037 control subjects who were matched for 18 variables, including age, sex, weight, and several cardiac risk factors. Weight changes were signifi cantly greater in the surgical group than in the control group among 3505 patients followed for 2 years (23.4% of body weight lost vs. 0.1% gained) and among 1268 patients followed for 10 years (16.1% of body weight lost vs. 1.6% gained). In a study of 1035 patients who underwent bariatric surgery, the mean BMI decreased from 50.0 to 32.6 at a median of 2.0 years of followup. 18 In general, weight loss with malabsorptive proce dures tends to be greater than weight loss with solely restrictive procedures. 15 Improvement in the conditions that are often associated with obesity has been consistently re ported after bariatric surgery. In a metaanalysis by Buchwald et al., 77% of patients with preop erative diabetes no longer required medication after surgery. Similar improvements were seen for patients with hyperlipidemia (83%), hypertension (66%), and sleep apnea (88%). 15 The SOS data sug gest that some of these benefits are less marked at 10 years than at 2 years, although they are still significant. 17 It has not been clearly established whether bariatric surgery results in reduced mortality as compared with medical management of obesity, although such a benefit is suggested in the results of several matched cohort studies. [18] [19] [20] Sjostrom has presented data from the SOS trial 21 showing that unadjusted overall mortality was reduced by 31.6% in the surgery group as compared with the control group, which was a significant reduction.
Cl inic a l Use
In 1991, the National Institutes of Health (NIH) convened a Consensus Development Conference on gastrointestinal surgery for severe obesity. 22 The recommendations resulting from the confer ence included the following criteria for bariatric surgery: a BMI of 40 or higher, or a BMI of 35 or higher in a patient with a highrisk condition such as severe sleep apnea, obesityrelated cardiomyop athy, or severe diabetes mellitus. Additional crite ria included failure of medical weight control and an absence of medical or psychological contrain dications, as well as the patient's understanding of the procedure and its risks and strong motiva tion to comply with the postsurgical regimen. These criteria make clear the need for a multidis ciplinary approach that includes medical, surgical, nutritional, and psychological assessment.
Evaluation of the surgical candidate should include a comprehensive nutritional and weight history, covering weight trends, previous weight loss efforts, and perceived obstacles to success ful weight management. 23 Current weight, height, and BMI should be determined. Although mea surement of waist circumference provides addi tional information regarding health risks, this in formation is not particularly useful in persons with a BMI above 40. 23 Secondary causes of obesity should be consid ered, although they do not usually account for severe obesity. Routine screening for Cushing's syndrome and hypothyroidism is not necessary unless clinical suspicion is high. 24 A medication history should be obtained; antidepressants, oral contraceptives, oral hypoglycemic agents, and oth er drugs can be associated with weight gain. 3 The medical evaluation should include assess ment for the conditions that commonly accom pany severe obesity, including diabetes, hyperten sion, hyperlipidemia, coronary artery disease, sleep apnea, pulmonary hypertension, and musculoskel etal disease. 3, 4, 25 Careful selective investigation of these conditions serves several purposes. It facili tates optimal medical management before sur gery, identifies problems that may influence the perioperative and postoperative course, and pro vides a baseline set of clinical data for evaluating the benefit of surgery.
The psychological evaluation of the candidate for bariatric surgery is one of the most important and difficult elements of the clinical assessment. A majority of patients presenting for bariatric procedures have one or more psychiatric disor ders 26 ; some studies suggest that patients with a diagnosis of an Axis I or Axis II disorder (accord ing to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition 27 ) are likely to lose less weight after surgery than those without such diagnoses. 28 Other psychosocial factors that have been associated with a suboptimal surgical out come include disturbed eating habits (e.g., binge eating), substance abuse, low socioeconomic sta tus, limited social support, and unrealistic expec tations of surgery. 28, 29 Patients undergoing bariatric surgery often be lieve they will lose more weight than is consis tent with clinical experience and may think that minimal personal effort or risk is involved. Un fortunately, such ideas are increasingly fostered by inaccurate information obtained from unreli able sources on the Internet and elsewhere. 30, 31 Preoperative education is important in improving the patient's understanding of the anticipated consequences of the procedure. 24 Specific contraindications to bariatric surgery are few. They include mental or cognitive impair ment that limits the patient's ability to under stand the procedure and thus precludes informed consent. Very severe coexisting medical condi tions, such as unstable coronary artery disease or advanced liver disease with portal hypertension, may in some instances render the risks of sur gery unacceptably high.
Perioperative care of patients undergoing bar iatric surgery requires specialized expertise and Restrictive operations for the treatment of morbid obesity and its coexisting conditions, popular today particularly because of laparoscopic surgical approaches, include adjustable gastric banding (Panel A) and vertical (sleeve) gastrectomy (Panel B). Roux-en-Y gastric bypass (Panel C), a procedure that combines restriction and malabsorption, is considered by many to be the gold standard because of its high level of effectiveness and its durability. More extreme malabsorption accompanies biliopancreatic diversion procedures, commonly performed with a duodenal switch (Panel D), in which a short, distal, common-channel length of small intestine severely limits caloric absorption. This procedure also includes a sleeve gastrectomy.
Copyright © 2007 Massachusetts Medical Society. All rights reserved. 35 RouxenY gastric bypass operations accounted for 1049 (92%) of the procedures. Among the patients who under went these procedures, the mean time in the operating room was 3.8 hours, 7.7% required intensive care, and the mean hospital stay was 3.5 days. Ninetyfour (8%) of the procedures were restrictive. In the group of patients who under went restrictive operations, the mean time in the operating room was 2.3 hours, only 1.1% re quired intensive care, and the mean hospital stay was 1.6 days.
A comprehensive plan for longterm patient care is necessary for bariatric surgery to have a reasonable chance of being both safe and suc cessful. The operation should not be performed unless systematic followup is available and unless the patient has made a commitment to participate in such care. As in the preoperative evaluation, postoperative management requires a coordinated approach involving expertise in medicine, surgery, psychology, and nutrition. 36 Unfortunately, many patients do not receive systematic postoperative care, and they may have suboptimal outcomes as a result. 37, 38 Estimates of the median hospital costs for bar iatric surgery range from approximately $10,000 to $14,000. 39 The Medicare physician fees for 2007 are $800 to $1,000 for laparoscopic adjustable gas tric banding and $1,300 to $2,000 for RouxenY gastric bypass and for biliopancreatic diversion with duodenal switch. 40 Longerterm costs are more difficult to determine, but one analysis sug gested that lifetime medical costs could be $59,000 to $75,000. 41
A dv er se Effec t s
In several large series, the mortality rate associat ed with bariatric surgery was 0.1% to 2.0%. 20, [42] [43] [44] [45] In the metaanalysis by Buchwald et al., operative mortality rates were 0.5% for gastric bypass, 0.1% for gastric banding, and 1.1% for malabsorptive procedures. 15 Common causes of death among patients undergoing bariatric surgery include pul monary embolism and anastomotic leaks. Factors that have been found to contribute to increased mortality include lack of experience on the part of the surgeon or the program, advanced patient age, male sex, severe obesity (BMI ≥50), and co existing conditions. 20, 32, 42, [44] [45] [46] [47] [48] [49] [50] Nonfatal perioperative complications include venous thromboembolism, anastomotic leaks, wound infections, bleeding, incidental splenec tomy, incisional and internal hernias, and early smallbowel obstruction. In the SOS trial, post operative complications occurred in 13% of pa tients, including bleeding in 0.5%, embolism or thrombosis in 0.8%, wound complications in 1.8%, and pulmonary complications in 6.1%. 17 Postoperative gastrointestinal complications of bariatric surgery are common. Nausea and vomit ing occur in more than 50% of patients undergo ing restrictive procedures, partly as a result of eating too much or too rapidly but sometimes because of anastomotic stricture or other mechan ical consequences of the operation. 36 The dump ing syndrome, a complex of neurohormonally mediated symptoms that include facial flushing, lightheadedness, palpitations, fatigue, and diar rhea, occurs in as many as 70% of patients after RouxenY gastric bypass. 24 Typically triggered by the ingestion of concentrated sugar, this syn drome may discourage patients from eating foods with a high sugar content, thus contributing to the beneficial effects of the operation. 51 Deficien cies of iron, calcium, folate, vitamin B 12 , and other nutrients occur after procedures with a compo nent of malabsorption, such as gastric bypass. With the more extensive procedures, such as bilio pancreatic diversion, protein malnutrition and deficiencies of the fatsoluble vitamins (A, D, E, and K) may occur. All of these deficiencies re quire regular monitoring and replacement. 24, 36 Other gastrointestinal complications include de hydration, bowel obstruction, anastomotic leaks, strictures, erosions, ulcers, adhesions, internal and incisional hernias, and cholelithiasis. 16, 36, 52 Patients who have undergone bariatric surgery may require subsequent readmission or reopera tion. In the study by the University HealthSystem Consortium, the rate of repeat operation was 3.7%, and the rate of readmission at 30 days 6.4%. 35 In one study of RouxenY gastricbypass procedures, more patients were readmitted within 12 or 36 months after the procedure (19.3% and 40.4%, respectively) than had been admitted for hospital care 12 or 16 months before the proce dure (7.9% and 19.4%, respectively). 53 Some of the postoperative readmissions were required for com plications, but others were for treatment of co existing conditions (e.g., joint replacement and abdominoplasty) that could be managed more definitively after weight loss.
A r e a s of Uncer ta in t y
The potential benefit of bariatric surgery for pa tients with mild obesity (BMI of 30 to 35) remains unclear. In a recent randomized, controlled trial, patients in this range who underwent laparo scopic adjustable gastric banding had more weight loss, greater resolution of the metabolic syn drome, and greater improvement in the quality of life than did patients who received medical therapy. 54 However, this remains an area of con troversy.
It is likewise uncertain whether patients with extremely severe obesity are appropriate candi dates for bariatric surgery. There are reasons for concern that the operative risk may be increased for such patients, partly because of technical difficulties in performing the procedure and prac tical management issues. 55 At least one report has suggested that mortality rates may be increased among patients with a BMI of 70 or more. 56 However, there is also a lack of comparison data with which to determine risk and longevity in patients who have not had surgery.
The role of bariatric procedures in patients out side the commonly defined age range (18 to 60 years) is not well established. It has been demon strated that the levels of risk and benefit among obese adolescents who undergo surgery are simi lar to those among older patients. However, many younger patients may not have sufficient insight to appreciate the consequences of the decision to undergo surgery or to cooperate fully with follow up care. 57 In addition, the longterm consequenc es of surgery are less clear in this population. For the elderly, at least one report has indicated that the benefits in terms of weight loss and im provement in coexisting conditions, although sig nificant, are not as great as in younger patients. 58 The changing popularity of specific bariatric surgical procedures over time suggests that the ideal procedure has not been definitively estab lished. In the United States, the RouxenY gastric bypass (open or laparoscopic) is the most common operation, but in Europe, laparoscopic adjustable gastric banding is performed more frequently. 59 Comparative studies indicate that laparoscopic gastric bypass is similar to open surgery in terms of weight loss, with fewer complications and less postoperative pain, but specific training in lapa roscopic techniques is required. 60, 61 Guidel ine s
Most clinical guidelines regarding the role of bariatric surgery have followed the lead of the 1991 NIH Health Consensus Development Con ference in concluding that such procedures should be considered for patients who have a BMI of 40 or more or for those who have a BMI of 35 or more with coexisting medical conditions. 22 These cri teria are endorsed by the National Heart, Lung, and Blood Institute in guidelines for the treat ment of obesity published in 1998 62 ; they are also endorsed in more recent guidelines published by the Institute for Clinical Systems Improvement, 63 the American Society for Bariatric Surgery, 64 the European Association for Endoscopic Surgery, 65 and other organizations. 16, [66] [67] [68] The American Col lege of Physicians has adopted a somewhat more conservative approach, recommending that sur gery be considered only in patients with a BMI of 40 or more who also have coexisting conditions. 69 All these guidelines generally concur that patients should have made previous attempts to lose weight, should be free of medical and psychologi cal contraindications, and should be cared for by a multispecialty team with experience in bariatric surgery and perioperative care.
R ec om mendat ions
The patient described in the vignette is a candi date for bariatric surgery on the basis of her BMI and coexisting medical conditions. She should be evaluated by an experienced surgeon at a center with established expertise in bariatric procedures and should undergo a comprehensive medical, surgical, nutritional, and psychological assess ment. It is important that her expectations for surgery be discussed in advance and that she re ceive full information about the anticipated risks and results of the operation. She should be re quired to make a commitment to an appropriate postoperative regimen of diet, exercise, and med ical and surgical followup care. On the basis of my own experience, I would recommend that she undergo a laparoscopic RouxenY gastric bypass, with some discussion and consideration of other surgical options. The detailed plan for her care should be discussed with her primary care phy sician, who should be recruited in the effort to provide the patient with appropriate preoperative and postoperative medical and psychological support. 
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